ETNB 89bio.com Net earnings per share for the last 12 months

Public company logo of 89bio, Inc. (ETNB)

Earnings per share over the last 12 months for 89bio, Inc. (ETNB) reflect a trend where the metric reached -3.58. The current trend is driven by a lack of operating leverage due to the testing phase. R&D efficiency is increasing through digital biochemical screening systems, while the retention of leading pharmacologists is secured by academic freedom and equity options, strengthening the company's potential for developing liver disease medications.

ETNB (89bio Pharma) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/15/2025

Analytical breakdowns and data insights for company 89bio Pharma (ETNB)

- stock price and consensus target price:
Stock Price 89bio Pharma|ETNB - Average Forecast Price
- market capitalization data:
Market Valuation 89bio, Inc.|ETNB - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share 89bio|ETNB - Book Capitalization|Market Capitalization to Book Value Ratio 89bio.com|ETNB - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity 89bio, Inc.|ETNB - Long-Term Liabilities to Capital|Short-Term Debt to Equity 89bio, Inc.|ETNB - Company Debts|Debts to Book Capitalization 89bio|ETNB - Long-Term Debt Volume|Company Short-Term Debt 89bio|Quick Liquidity 89bio.com
- net income and valuation multiples indicators:
ETNB - Net Income|Expected Net Income 89bio, Inc.|ETNB - Business Payback Period|Forward P/E Multiple 89bio Corp|ETNB - Price/Earnings to Growth Ratio|EV/EBITDA Multiple 89bio|ETNB - Operating income before deduction of amortization|Earnings per share for the last twelve months 89bio|ETNB - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months 89bio.com|ETNB - Earnings per share increase in current year|Earnings growth forecast for next year 89bio, Inc.
- sales and revenue data:
ETNB - Company Gross Revenue|Company Projected Revenue 89bio Corp|ETNB - Market Cap to Revenue Ratio|Forward P/S Multiple 89bio Pharma
Fundamental company valuation:89bio Inc (ETNB)
Mass-produced product of 89bio Corp

This indicator measures the actual efficiency of profit generation per share annually, excluding distortions from share issuances or buybacks. By analyzing the annual net income per share trend, an investor identifies the reversal point of fundamental momentum, which is critical for 89bio, Inc. (ETNB), as its future pricing power and high margins depend on the successful market launch of its therapy.

Competitors of 89bio, Inc.

Ascendis - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Madrigal Pharma|CORT (Corcept Therapeutics Incorporated) - Net earnings per share for the last 12 months|RYTM: Earnings per share for the last four quarters|AKRO (Akero Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Metsera Inc|Net earnings per share (EPS TTM) MLTX|Earnings per share for the last twelve months CRNX (Crinetics Pharmaceuticals, Inc.)|Earnings per share for the last twelve months newamsterdampharma.com NAMS|Soleno Therapeutics Corp (SLNO) - Net earnings per one share for the last twelve months|FOLD - Earnings per share for the last twelve months|AGIO: Earnings per share for the last twelve months|GPCR: Net earnings per share (EPS TTM)|MDXG - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Rezolute Bio|Lexicon Corp (LXRX) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months mbxbio.com (MBX)|Net earnings per share (EPS TTM) altimmune.com (ALT)|Net earnings per share (EPS TTM) AARD (aardvarktherapeutics.com)|Net earnings per share for the last four quarters Sagimet Biosciences Inc. (SGMT)|BioAge Labs, Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Biomea Fusion Corp BMEA|QNCX: Net earnings per share (EPS TTM)|Fractyl Health, Inc. (GUTS) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months VTVT|Agape ATP Corporation - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) PLUR|SYBX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) LPCN (lipocine.com)|Net earnings per share (EPS TTM) Matinas BioPharma MTNB|SPRB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Galecto Corp|CTCX (Carmell Corp) - Net earnings per share for the last 12 months|Lumos Pharma Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months ONVO|Net earnings per one share for the last twelve months Radius Recycling, Inc. RDUS